Voluson Expert 18; Voluson Expert 20; Voluson Expert 22
GE Medical Systems Ultrasound and Primary care Diagnostics, LLC · Decision date Oct 2, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on October 2, 2026 for K261933, a traditional 510(k) from GE Medical Systems Ultrasound and Primary Care Diagnostics, LLC covering the Voluson Expert 18, 20 and 22 ultrasound systems. The submission was received June 9, 2026 under 21 CFR 892.1550 (ultrasonic pulsed Doppler imaging system, Class II), with primary product code IYN and subsequent codes IYO, ITX and QIH; the review specialty and panel were radiology. SESE is a clearance, not a PMA approval.
The summary names K252328, the prior Voluson Expert 18/20/22, as primary predicate and K251169 Vivid Pioneer as a reference device. Listed changes include support for Vscan Air SL and CL wireless probes, the eX7C probe described as substantially equivalent to the eM6C G3-D, and migration of the already cleared 6Sc-D probe. Model differentiation is by locked features: Expert 18 is the lower version, Expert 20 excludes the eM6C G3 and eX7C electronic probes, and Expert 22 allows all probes and functions. The documents do not give clinical performance data supporting these claims.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Oct 2, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261933
- Regulatory pathway
- 510(k) premarket notification
- Product code
- IYN
- Decision code
- SESE
- Decision date
- Oct 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Imaging, Pulsed Doppler, Ultrasonic.
- Product code
- IYN
- FDA device class
- 2
FDA decision timeline
K261933 received
Application receipt date recorded by FDA.
K261933 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code IYN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 510(k) clearance | Oct 16, 2026 | FDA | |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 510(k) clearance | Oct 8, 2026 | FDA | |
| Samsung Medison Co., Ltd. | 510(k) clearance | Oct 8, 2026 | FDA | |
| Philips Ultrasound, LLC | 510(k) clearance | Sep 25, 2026 | FDA | |
| Samsung Medison Co., Ltd. | 510(k) clearance | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
GE Medical Systems Ultrasound and Primary care Diagnostics, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Waukesha, WI
Sources and methodology
- Original FDA record: K261933
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


